Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
107.8 USD | -1.96% | -6.92% | -4.27% |
Feb. 16 | Qorvo Insider Sold Shares Worth $345,078, According to a Recent SEC Filing | MT |
Feb. 01 | BNP Paribas Exane Adjusts Qorvo's Price Target to $130 From $115, Maintains Outperform Rating | MT |
Evolution of the average Target Price on Qorvo, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Qorvo, Inc.
BNP Paribas Exane | |
Susquehanna | |
Craig-Hallum | |
Citigroup | |
Goldman Sachs | |
Raymond James | |
JPMorgan Chase | |
Rosenblatt Securities | |
UBS | |
Piper Sandler | |
Morgan Stanley | |
Summit Insights Group | |
Wells Fargo Securities | |
Wolfe Research | |
Needham & Co. | |
BMO Capital | |
Morningstar | |
Mizuho Securities | |
Stifel Nicolaus | |
Cowen | |
Barclays | |
KGI Securities | |
BofA Securities | |
Benchmark Capital | |
Oppenheimer | |
Argus | |
WestPark Capital |
EPS Revisions
- Stock Market
- Equities
- QRVO Stock
- Consensus Qorvo, Inc.